Targeted nucleotide sequence delivery and integration system
AssigneeAvigen, Inc.
InventorsGeorges Natsoulis, Richard T. Surosky
Life of this patent
Estimating the term…
Loading patent…
AssigneeAvigen, Inc.
InventorsGeorges Natsoulis, Richard T. Surosky
Estimating the term…
A novel targeted nucleotide sequence delivery and integration system is provided. The integration system employs nucleic acid constructs having a targeting sequence capable of binding AAV Rep and a heterologous nucleotide sequence arranged relative to the targeting sequence such that the targeting sequence is capable of directing the integration of the heterologous sequence into a target site in a recipient genome. The system further employs Rep expression products which provide integration functions effective to mediate the site-specific integration of the targeting sequence and the heterologous sequence into the recipient genome. Methods are described, whereby the nucleotide sequence integration system can deliver and efficiently integrate large nucleotide sequences into target sites in recipient cell genomes. Therapeutic methods are also provided, wherein the integration systems are used to insert various therapeutically relevant nucleotide sequences into selected cells from a subject.
An integration system for inserting a selected nucleotide sequence into a suitable recipient cell genome, said system comprising the combination of:
A method of integrating a selected nucleotide sequence into a recipient cell genome, said method comprising the steps:
Dependencies are inferred from the claim text.